AFP and neoplasm: Women had a lower overall likelihood of LT receipt in model 2 (SHR: 0.93; 95% CI, 0.87-0.98), with similar findings in sensitivity analyses for ALD (SHR: 0.86; 95% CI, 0.77-0.98), compared with men, after adjusting for age, sex, height, race/ethnicity, history of diabetes mellitus, MELD score, number of tumors, tumor size, and alpha-fetoprotein levels.